KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Net Cash Flow (2016 - 2025)

Charles River Laboratories International has reported Net Cash Flow over the past 17 years, most recently at $2.8 million for Q4 2025.

  • For Q4 2025, Net Cash Flow fell 61.39% year-over-year to $2.8 million; the TTM value through Dec 2025 reached -$8.4 million, up 86.33%, while the annual FY2025 figure was -$8.4 million, 86.33% up from the prior year.
  • Net Cash Flow for Q4 2025 was $2.8 million at Charles River Laboratories International, down from $27.5 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $227.0 million in Q1 2021 and troughed at -$249.6 million in Q2 2021.
  • A 5-year average of -$3.5 million and a median of $1.4 million in 2023 define the central range for Net Cash Flow.
  • Biggest five-year swings in Net Cash Flow: skyrocketed 311.29% in 2021 and later tumbled 314771.43% in 2024.
  • Year by year, Net Cash Flow stood at $19.6 million in 2021, then skyrocketed by 54.06% to $30.2 million in 2022, then skyrocketed by 251.64% to $106.1 million in 2023, then plummeted by 93.05% to $7.4 million in 2024, then crashed by 61.39% to $2.8 million in 2025.
  • Business Quant data shows Net Cash Flow for CRL at $2.8 million in Q4 2025, $27.5 million in Q3 2025, and -$59.7 million in Q2 2025.